Back to results

CompletedPhase 4

Empagliflozin Impact on Hemodynamics in Patients With Heart Failure

NCT03030222

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Southern California

Los Angeles, California, United States

+9 additional locations

View on ClinicalTrials.gov

Empagliflozin Impact on Hemodynamics in Patients With Heart Failure — TrialFind